Lv4
710 积分 2024-08-07 加入
A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma
6天前
已完结
Novel molecular targets of muscle wasting in cancer patients
6天前
已完结
NK cell-based therapeutics for lung cancer
6天前
已完结
The repeated administration of rhIL-12 for 14 weeks in rhesus monkeys: A toxicity assessment
7天前
已完结
供者自然杀伤细胞输注及IL-2、IL-15治疗在异基因及单倍型相合造血干细胞移植中作用的实验研究
10天前
已完结
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
12天前
已完结
Tumour-targeting bacteria engineered to fight cancer
1个月前
已完结
皖公网安备34019202002308
